Abstract
Background:
Genetic testing identifies underlying causative mutations in many children with kidney diseases. However, several factors prevent the widespread implementation of this useful tool in clinical practice. We aim to evaluate the perception and current state of genetic testing utilization among pediatric nephrologists.
Methods:
This study involved a nationwide survey including questions about the availability of genetic testing, perceptions, modalities, indications, and barriers to routine utilization in clinical practice.
Results:
Forty pediatric nephrologists completed the survey. Over 60% of respondents reported that genetic testing services were available at their institutions and over 70% reported that whole exome sequencing was the most frequent genetic testing modality. Barriers to genetic testing were mostly financial or due to a lack of awareness among providers. Glomerulopathies, tubulopathies, and ciliopathies were the most common reasons for sending genetic samples.
Conclusion:
Despite the availability at most centers, pediatric nephrologists face difficulties in interpreting genetic test results.
Keywords
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
